This meta-analysis suggested that high SHP2 expression was positively correlated with early clinical stage in hepatocellular carcinoma, not associated with clinical stage in laryngeal carcinoma, pancreatic carcinoma, gastric carcinoma, esophagus carcinoma, colorectal carcinoma, and thyroid carcinoma. Here, PTPN11 is linked to colorectal carcinoma.